beta-lapachone has been researched along with Alcoholic Fatty Liver in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shin, S | 1 |
| Park, J | 2 |
| Li, Y | 1 |
| Min, KN | 1 |
| Kong, G | 1 |
| Hur, GM | 1 |
| Kim, JM | 1 |
| Shong, M | 1 |
| Jung, MS | 1 |
| Park, JK | 1 |
| Jeong, KH | 1 |
| Park, MG | 1 |
| Kwak, TH | 1 |
| Brazil, DP | 1 |
1 other study available for beta-lapachone and Alcoholic Fatty Liver
| Article | Year |
|---|---|
β-Lapachone alleviates alcoholic fatty liver disease in rats.
Topics: Alcohol Dehydrogenase; Aldehyde Dehydrogenase; AMP-Activated Protein Kinases; Animals; Cells, Cultur | 2014 |